| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 8 | -1.09M | 100% | $71.94 | -$78.5M |
| Net | -8 | -1.09M | -100% | -$78.5M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Christopher D. Alafi | Director | $377M | May 27, 2021 | ||
| Sharon Mates | Chairman and CEO, Director | $92M | -$50.5M | -35.4% | Dec 4, 2024 |
| Rory B. Riggs | Director | $8.57M | -$337K | -3.79% | Sep 30, 2024 |
| Richard A. Lerner | Director | $7.16M | Sep 30, 2021 | ||
| Joel S. Marcus | Director | $3.87M | -$1.81M | -31.8% | Jun 23, 2024 |
| Mark Neumann | EVP, Chief Commercial Officer | $2.72M | -$4.11M | -60.2% | Aug 16, 2024 |
| Sanjeev Narula | Executive Vice President & CFO | $2.4M | Aug 12, 2024 | ||
| Suresh K. Durgam | EVP, Chief Medical Officer | $1.82M | -$5.77M | -76.1% | Mar 7, 2024 |
| Robert L. Van Nostrand | Director | $777K | -$2.98M | -79.3% | Jun 28, 2024 |
| Michael Halstead | President | $537K | -$9.72M | -94.8% | Nov 12, 2024 |
| Lawrence J. Hineline | SVP of Finance, CFO | $372K | -$3.21M | -89.6% | Mar 7, 2024 |
| Eduardo Rene Salas | Director | $118K | Jun 23, 2024 | ||
| Michael Rawlins | Director | Jun 9, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|